Last reviewed · How we verify
Licensed Tdap vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Licensed Tdap vaccine (Licensed Tdap vaccine) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Licensed Tdap vaccine TARGET | Licensed Tdap vaccine | Sanofi Pasteur, a Sanofi Company | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Licensed Tdap vaccine CI watch — RSS
- Licensed Tdap vaccine CI watch — Atom
- Licensed Tdap vaccine CI watch — JSON
- Licensed Tdap vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Licensed Tdap vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/licensed-tdap-vaccine. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab